Skip to main content
. 2024 Mar 13;10:58. doi: 10.1038/s41531-024-00667-5

Fig. 2. Survival against key clinical events.

Fig. 2

A Proportion of patients not started on Levodopa, B Proportion of patients not started on PD medications, C Proportion of patients with HY ≤3 (smaller or equal) (MGB, HBS), D The proportion of patients who have not experienced Cognitive Decline Proxy (MGB, HBS, Optum). Shaded regions represent 95% confidence intervals.